Clinical Trials Logo

Clinical Trial Summary

With the development of endoscopic technology, ERCP has been widely used in the diagnosis and treatment of pancreatobiliary diseases, and has become the first treatment for most of the biliary and pancreatic diseases. Postoperative ERCP pancreatitis (PEP) is the most common and serious complication after ERCP. The purpose of this study was to explore methods for preventing postoperative pancreatitis. 1. Participants: Patients with high-risk factors associated with PEP were included in the no-obvious patients who underwent therapeutic ERCP in our hospital from June 2018 to December 2019. 2. Research methods: Patients were randomly divided into indometacin suppositories, indomethacin suppositories and pancreatic stents. 3. Statistical methods: SPSS 13.0 statistical software was used. The measurement data was expressed as x± s, and t-test or non-parametric test was used. Chi-square test was used for count data.


Clinical Trial Description

Patients with high risk factors for PEP who will be examined and diagnosed by ERCP at 2018.06-2019.12 in the First People's Hospital of Hangzhou are randomly divided into two groups. 2. Record the relevant indicators of each group of patients: 1 before and after surgery 3, 12, 24 h serum amylase changes 2 patients with abdominal pain, abdominal distension, fever, vomiting and abdominal signs of change; 3 hospital days; 4 CT severity index (CT severity Index, CTSI score: Balthazar 5 scores were scored as 0 to 4 points; according to the scope of necrosis was divided into no, <33%, 33% to 50%,> 50%, respectively rated as 0, 2, 4 and 6 points. Addition of the two scores is the CTSI score. 5 According to the diagnostic criteria for postoperative ERCP pancreatitis, PEP will be diagnosed in patients with persistent abdominal pain within 24 hours after ERCP and blood amylase increase by more than 3 times the normal value. Observed 2 groups of post-ERCP pancreatitis, severe pancreatitis and adverse events Incidence. 3. Analyze and compare the above indicators and observe the effect of the two methods on the reduction of blood amylase level and incidence of pancreatitis. It is clear that rectal administration of preoperative indomethacin suppository has the same protection against PEP as pancreatic stenting effect. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03643900
Study type Interventional
Source First People's Hospital of Hangzhou
Contact
Status Completed
Phase N/A
Start date August 8, 2018
Completion date August 18, 2021

See also
  Status Clinical Trial Phase
Completed NCT00061269 - Videoendoscopic Drainage of Infected Pancreatic Collections N/A
Recruiting NCT05530772 - Immediate vs. On-demand Endoscopic Necrosectomy in Infected Walled-off Pancreatic Necrosis N/A
Not yet recruiting NCT00508729 - Effect of Traditional Chinese Medicine on GI Function Recovery and Nutrition Support in SAP Phase 2/Phase 3
Recruiting NCT00506337 - Evaluation of Effect of Integrated Treatment by Traditional Chinese and Western Medicine for Severe Acute Pancreatitis Phase 2/Phase 3
Recruiting NCT05601687 - Endoscopic Step-up Approach vs Aggressive Debridement of Large Pancreatic Walled-off Necrosis N/A
Completed NCT03923686 - Lumen-apposing Metal Stent With or Without Coaxial Plastic Stent for Treatment of Walled-off Pancreatic Necrosis N/A
Completed NCT02473406 - Thymosin Alpha 1 in the Prevention of Pancreatic Infection Following Acute Necrotizing Pancreatitis Phase 4
Recruiting NCT05451901 - Immediate Necrosectomy vs. Step-up Approach for Walled-off Necrosis N/A
Recruiting NCT04443595 - Dual-scopic Pancreatic Necrosectomy (DPN) N/A
Not yet recruiting NCT06134024 - The Role of Double Pigtail Plastic Stents During Endoscopic Transmural Drainage of Pancreatic Fluid Collections. N/A
Not yet recruiting NCT02691598 - Dexmedetomidine Hydrochloride in the Prevention of Organ Failure Following Severe Acute Pancreatitis Phase 4
Completed NCT00061438 - A Study to Determine if Antibiotics Prevent Infection in the Pancreas of Patients Where Part of the Pancreas Has Died Phase 4
Terminated NCT03245619 - Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Investigation of GSK3335065 Intravenous (IV) Infusion in Healthy Adults Phase 1
Recruiting NCT02133014 - The Study of Laparoscopic-assisted Percutaneous Catheter-directed Drainage to Treat Early Severe Acute Pancreatitis N/A